[
  {
    "ts": null,
    "headline": "Cytokinetics Nears Approval: 'Buy' The New Potential Cardiology Franchise With Aficamten",
    "summary": "Cytokinetics is now rapidly moving into commercialization efforts with Aficamten. Read more to see why I rate CYTK stock a buy.",
    "url": "https://finnhub.io/api/news?id=28c160bc38a4681e6328673b4317838cc6b82908dda9e665fd1c62ea521a99a2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742120567,
      "headline": "Cytokinetics Nears Approval: 'Buy' The New Potential Cardiology Franchise With Aficamten",
      "id": 133183194,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1403947845/image_1403947845.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Cytokinetics is now rapidly moving into commercialization efforts with Aficamten. Read more to see why I rate CYTK stock a buy.",
      "url": "https://finnhub.io/api/news?id=28c160bc38a4681e6328673b4317838cc6b82908dda9e665fd1c62ea521a99a2"
    }
  },
  {
    "ts": null,
    "headline": "Buy 7 'Safer' Dividend Dogs Of 23 February Barron's Better Bets Than T-Bills",
    "summary": "Seven of the ten lowest-priced BBB \"Safer\" dividend stocks meet the dogcatcher ideal. Read more to see the picks.",
    "url": "https://finnhub.io/api/news?id=3c26fd4031456d6ee6dcb22ca2ad10ae18ab63411b2d0e4a924db04669974e16",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742116856,
      "headline": "Buy 7 'Safer' Dividend Dogs Of 23 February Barron's Better Bets Than T-Bills",
      "id": 133182987,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/495220683/image_495220683.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Seven of the ten lowest-priced BBB \"Safer\" dividend stocks meet the dogcatcher ideal. Read more to see the picks.",
      "url": "https://finnhub.io/api/news?id=3c26fd4031456d6ee6dcb22ca2ad10ae18ab63411b2d0e4a924db04669974e16"
    }
  }
]